INTAJAC 5MG TABLET (Tofacitinib 5mg) Rheumatoid Arthritis Guide
INTAJAC 5MG TABLET contains Tofacitinib 5mg, a Janus kinase inhibitor prescribed for inflammatory conditions like rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
INTAJAC 5MG TABLET
INTAJAC 5MG TABLET (Tofacitinib 5mg): Comprehensive Guide and Benefits
Introduction to INTAJAC 5MG TABLET (Tofacitinib 5mg)
INTAJAC 5MG TABLET: A Janus Kinase (JAK) Inhibitor Immunomodulatory Medicine
INTAJAC 5MG TABLET is a prescription immunomodulatory medicine containing Tofacitinib 5mg. It belongs to the drug class Janus Kinase (JAK) Inhibitors and is used for managing inflammatory autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis under specialist medical supervision. (1mg)
INTAJAC 5MG TABLET works by reducing abnormal immune system activity responsible for inflammation. Tofacitinib blocks specific Janus kinase pathways involved in immune signalling, helping decrease inflammatory responses associated with autoimmune disorders. This medicine is prescription-only and requires regular monitoring by a healthcare professional. (1mg)
Key Benefits of INTAJAC 5MG TABLET (Tofacitinib 5mg)
Helps reduce inflammation associated with autoimmune disorders.
Supports management of rheumatoid arthritis symptoms.
Helps control inflammatory activity in psoriatic arthritis.
Supports ulcerative colitis management under medical supervision.
Helps improve joint function and quality of life in eligible patients.
How INTAJAC 5MG TABLET (Tofacitinib 5mg) Works
INTAJAC 5MG TABLET contains Tofacitinib, a selective Janus kinase (JAK) inhibitor. It works by blocking JAK enzymes involved in signalling pathways of cytokines and growth factors that regulate immune cell activity. By reducing excessive immune signalling, Tofacitinib helps decrease inflammation and immune-mediated tissue damage associated with autoimmune diseases.
Usage Instructions for INTAJAC 5MG TABLET (Tofacitinib 5mg)
Take INTAJAC 5MG TABLET exactly as prescribed by your doctor.
Swallow the tablet whole with water; do not crush or chew.
Take it at the same time each day for consistent therapeutic effect.
Complete recommended blood tests and medical monitoring during treatment.
Do not stop or change the dosage without consulting your healthcare provider.
Medicinal Advantages of INTAJAC 5MG TABLET (Tofacitinib 5mg)
Provides targeted immune pathway modulation through JAK inhibition.
Helps manage chronic inflammatory joint conditions.
Supports reduction of inflammation-related symptoms.
Provides an oral treatment option for selected autoimmune disorders.
Helps maintain disease control when used under specialist supervision.
NOTE: INTAJAC 5MG TABLET is a prescription-only medicine. It requires medical supervision because monitoring of blood counts, liver function, kidney function, lipid levels, and infection risk may be necessary during treatment. Patients with active infections or certain medical conditions should consult their doctor before use. (1mg)
Off-Label Uses of INTAJAC 5MG TABLET (Tofacitinib 5mg)
Tofacitinib may occasionally be considered for conditions outside approved indications based on specialist evaluation and current medical evidence.
Physician-directed treatment of selected inflammatory immune disorders.
Specialist-guided management of certain dermatological inflammatory conditions.
Individualised autoimmune disease treatment approaches.
Disclaimer: Off-label uses should only occur under physician supervision and may not be approved in all countries.
Expert Advice for Optimal Use
Take INTAJAC 5MG TABLET regularly as prescribed.
Attend scheduled medical check-ups and laboratory monitoring.
Inform your doctor immediately about signs of infection.
Avoid self-adjusting the dose or stopping treatment suddenly.
Discuss vaccination requirements with your healthcare provider.
Inform your doctor about all medicines and supplements being used.
Precautions
Cardiovascular Health
Patients with cardiovascular risk factors should inform their doctor before starting Tofacitinib therapy. Medical evaluation may be required based on individual risk factors.
Liver & Kidney Function
Patients with liver or kidney impairment may require medical assessment and dose adjustments before and during treatment.
Pregnancy & Breastfeeding
Pregnant or breastfeeding women should use INTAJAC 5MG TABLET only after consulting their healthcare provider to evaluate potential benefits and risks.
Drug Interactions
Inform your doctor about all medicines being taken, especially immunosuppressants, biologic therapies, and medicines affecting Tofacitinib metabolism.
Existing Medical Conditions
Patients with infections, tuberculosis history, hepatitis, blood disorders, cancer history, or immune-related conditions should inform their doctor before use.
Storage Instructions
Store below 30°C in a dry place. (1mg)
Keep tablets in the original packaging.
Protect from moisture and direct sunlight.
Keep away from children.
Do not use after the expiry date mentioned on the pack.
Frequently Asked Questions (FAQs)
Q: What is INTAJAC 5MG TABLET used for?
A: INTAJAC 5MG TABLET contains Tofacitinib and is used for managing inflammatory autoimmune conditions such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. (1mg)
Q: What is the active ingredient in INTAJAC 5MG TABLET?
A: The active ingredient is Tofacitinib 5mg. (1mg)
Q: What type of medicine is INTAJAC 5MG TABLET?
A: It is a Janus kinase (JAK) inhibitor and immunomodulatory medicine.
Q: How does INTAJAC 5MG TABLET work?
A: It blocks Janus kinase pathways involved in immune signalling, helping reduce excessive inflammation.
Q: Can INTAJAC 5MG TABLET be stopped suddenly?
A: No. Treatment should only be stopped or changed after consultation with your doctor.
Q: Does INTAJAC 5MG TABLET require regular monitoring?
A: Yes. Doctors may recommend periodic blood tests and health assessments during treatment. (1mg)
Q: Who should consult a doctor before taking INTAJAC 5MG TABLET?
A: Patients with infections, liver or kidney problems, tuberculosis history, blood disorders, pregnancy, breastfeeding, or those taking other immune-modifying medicines should consult their doctor before use.
Product Tags
INTAJAC 5MG TABLET, INTAJAC TABLET, Tofacitinib 5mg, Tofacitinib tablet, JAK inhibitor medicine, Janus kinase inhibitor, rheumatoid arthritis medicine, psoriatic arthritis treatment, ulcerative colitis medicine, ankylosing spondylitis therapy, autoimmune disease treatment, immunomodulator medicine, inflammatory disorder medicine, Intas Pharmaceuticals INTAJAC, prescription autoimmune medicine, arthritis treatment tablet, immune system therapy, oral JAK inhibitor, rheumatology medicine, inflammatory disease management.
